Hepatitis B reactivation in patients positive for hepatitis B surface antigen undergoing autologous hematopoietic cell transplantation

Leukemia and Lymphoma

Volumn 44, Issue 8, 2003, Pages 1281-1285

  Ma, Shing Yan ^a   Lau, George K K ^a   Cheng, Vincent C C ^a   Liang, Raymond ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Autologous stem cell transplantation; Chemotherapy; Hepatitis B; Reactivation

Indexed keywords

ADEFOVIR DIPIVOXIL; ALPHA INTERFERON; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CLEVUDINE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; ELVUCITABINE; EMTRICITABINE; ENTECAVIR; FAMCICLOVIR; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; NUCLEOSIDE ANALOG; PROSTAGLANDIN E2; VIRUS DNA;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; BLOOD; CHRONIC HEPATITIS; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; METHODOLOGY; MORBIDITY; MORTALITY; NEPHROTOXICITY; PATIENT MONITORING; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREMEDICATION; PRIORITY JOURNAL; RECURRENT DISEASE; RELIABILITY; REVIEW; VIRUS ACTIVATION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS TITRATION;

EID: 0038804139     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000083343     Document Type: Review

References (57)

1. Lau, G.K.K., Leung, Y.H., Daniel, Y.T.F., Wing-yan, A., Yok-lam, K., Albert, L., Ji-lin, H., Yu-mei, W., Amin, N. and Raymond, L. (2002) "High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous haematopoietic cell transplantation", Blood 99, 2324-2330.
2. Liang, R., Lau, G.K.K. and Kwong, Y.L. (1999) "Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem", J. Clin. Oncol. 17, 394-398.
3. Webster, A., Brenner, M.K., Prentice, H.G. and Griffiths, P.D. (1989) "Fatal hepatitis B reactivation after autologous bone marrow transplantation", Bone Marrow Transplant. 4(2), 207-208.
4. Ustun, C., Koc, H., Karayalcin, S., et al. (1997) "Hepatitis B virus infection in allogeneic bone marrow transplantation", Bone Marrow Transplant. 20, 289-296.
5. Pariente, E.A., Goudeau, A., Dubois, F., et al. (1988) "Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation", Dig. Dis. Sci. 33, 1185-1191.
6. Dhedin, N., Douvin, C., Kuentz, M., et al. (1998) "Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc", Transplantation 66, 616-619.
7. Martin, B.A., Rowe, J.M., Kouides, P.A. and DiPersio, J.F. (1995) "Hepatitis B reactivation following allogeneic bone marrow transplantation: a case report and review of the literature", Bone Marrow Transplant. 15, 145-148.
8. Chen, P.M., Liu, J.H., Fan, F.S., et al. (1995) "Liver disease after bone marrow transplantation: the Taiwan experience", Transplantation 59, 1139-1143.
9. Iwai, K., Tashima, M., Itoh, M., et al. (2000) "Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period", Bone Marrow Transplant. 25, 105-108.
10. Kostaridou, S., Ladis, V., Kattamis, A., Laras, A. and Hadziyannis, S.J. (1998) "HBeAg-negative hepatitis B in a previously thalassemic patient during immunosuppressive therapy for chronic GVHD", Bone Marrow Transplant. 22, 919-921.
11. Caselitz, M., Link, H., Hein, R., et al. (1997) "Hepatitis B associated liver failure following bone marrow transplantation", J. Hepatol. 27, 572-577.
12. Lau, G.K., Liang, R., Chiu, E.K., Lee, C.K. and Lam, S.K. (1995) "Loss of HBsAg in chronic hepatitis B carrier following high dose chemotherapy and autologous peripheral blood stem cell rescue for lymphoma", Am. J. Haematol. 50(4), 317-318.
13. Mason, A.L., Wick, M., White, H.M., Benner, K,G., Lee, R.G., Regenstein, F., Riely, C.A., Bain, V.G., Campbell, C. and Perrillo, R.P. (1993) "Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatits", Gastroenterology 105(1), 237-244.
14. Hoofnagle, J.H., Dusheiko, G.M., Schafer, D.F., et al. (1982) "Reactivation of chronic hepatitis B virus infection by cancer chemotherapy", Ann. Intern. Med. 96, 447-449.
15. Davis, G.L. and Hoofnagle, J.H. (1987) "Reactivation of chronic hepatitis B virus infection", Gastroenterology 92, 2028-2031.
16. McMillan, J.S., Shaw, T., Angus, P.W. and Locarnini, S.A. (1995) "Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro", Hepatology 22, 3643.
17. Wands, J.R., Chura, C.M., Roll, F.J. and Maddrey, W.C. (1975) "Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders", Gastroenterology 68, 105-112.
18. Nagington, J., Cossart, Y.E. and Cohen, B.J. (1977) "Reactivation of hepatitis B after transplantation operations", Lancet 68, 105-112.
19. Scullard, G.H., Smith, C.I., Merigan, T.C., Robinson, W.S. and Gregory, P.B. (1981) "Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B", Gastroenterology 81, 987-991.
20. Galbraith, R.M., Eddleston, A.L.W.F., Wiiliams, R., Zuckerman, A.J. and Bagshawe, K.D. (1975) "Fulminant hepatic failure in leukemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy", Lancet 2, 528-530.
21. Jones, R.J., Lee, K.S. and Saral, R. (1987) "Venoocclusive disease of the liver following bone marrow transplantation", Transplantation 44(6), 778-783.
22. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. and Thomas, E.D. (1974) "Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors", Transplantation 18(4), 295-304.
23. Steinberg, J.L., Yeo, W., Zhong, S., et al. (2000) "Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role", J. Med. Virol. 60, 249-255.
24. Cooksley, W.G. and McIvor, C.A. (1995) "Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation", Biomed. Pharmacother. 49(3), 117-124.
25. Duclos-Vallee, J.C., Laurent-Puig, P., Loriot, M.A., Buffet, C. and Etienne, J.P. (1994) "Fatal reactivation of hepatitis B virus mutant following cytotoxic treatment", J. Hepatol. 21(6), 1152.
26. McIvor, C., Morton, J., Bryant, A., Cooksley, W.G., Durrant, S. and Walker, N. (1994) "Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation", Ann. Intern. Med. 121, 274-275.
27. Yoshiba, M., Sekiyama, K., Sugata, F., et al. (1992) "Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment", Dig. Dis. Sci. 37, 1253-1259.
28. Talbodec, N., Loriot, M.A., Gigou, M., Guigonis, V, Boyer, N., Bezeaud, A., Erlinger, S., Benhamou, J.P. and Marcellin, P. (1995) "Hepatitis B virus precore mutations and HbeAg negative reactivation of chronic hepatitis B after interferon therapy", Liver 15(2), 93-98.
29. Kryger, P. (1985) "Significance of anti-HBc IgM in the differential diagnosis of viral hepatitis", J. Virol. Methods 10(4), 283-289.
30. Chau, K.H., Hargie, M.P., Decker, R.H., Mushahwar, I.K. and Overby, L.R. (1983) "Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc", Hepatology 3(2), 142-149.
31. Colloredo Mels, G., Bellati, G., Leandro, G., Brunetto, M.R., Vicari, O., Piantino, P., Borzio, M., Angeli, G., Ideo, G. and Bonino, R (1993) "Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations", Arch. Virol. Suppl. 8, 203-211.
32. Carman, W.F., Korula, J., Wallace, L., MacPhee, R., Mimms, L. and Decker, R. (1995) "Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA", Lancet 3345(8962), 1406-1407.
33. Lau, J.Y., Bird, G.L., Gimson, A.E., et al. (1991) "Treatment of HBV reactivation after withdrawal of immunosuppression", Lancet 337, 802.
34. Lok, A.S., Liang, R.H., Chiu, E.K., Wong, K.L., Chan, T.K. and Todd, D. (1991) "Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study", Gastroenterology 100, 182-188.
35. Lai, C.L., Chien, R.N., Leung, N.W., et al. (1998) "A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group", N. Engl. J. Med. 339, 61-68.
36. Dienstag, J.L., Schiff, E.R., Wright, T.L., et al. (1999) "Lamivudine as initial treatment for chronic hepatitis B in the United States", N. Engl. J. Med. 341, 1256-1263.
37. Main, J., Brown, J.L., Howells, C., Galassini, R., Crossey, M., Karayiannis, P., Georfiou, P., Atkinson, G. and Thomas, H.C. (1996) "A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection", J. Viral Hepat. 3(4), 211-215.
38. Trepo, C., Jezek, P., Atkinson, G., et al. (2000) "Famciclovir in chronic hepatitis B: results of a dose-finding study", J. Hepatol. 32, 1011-1018.
39. de Man, R.A., Marcellin, P., Habal, F., et al. (2000) "A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B", Hepatology 32, 413-417.
40. Lau, G.K.K., Lie, A.K.W., Kwong, Y.L., et al. (2000) "A case-controlled study on the use of HBsAg positive donors for allogeneic hematopoietic cell transplantation", Blood 96, 452-458.
41. Lau, G.K.K., Tsiang, M., Hou, J., et al. (2000) "Combination therapy with lamivudine and famciclovir for Chronic hepatitis B infected Chinese: a viral dynamics study", Hepatology 32, 394-399.
42. Yeo, W., Steinberg, J.L., Tam, J.S., et al. (1999) "Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy", J. Med. Virol. 59, 263-269.
43. Maguire, C.M., Crawford, D.H., Hourigan, L.F., et al. (1999) "Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy", J. Gastroenterol. Hepatol. 14, 801-803.
44. Clark, F.L., Drummond, M.W., Chambers, S., et al. (1998) "Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma", Ann. Oncol. 9, 385-387.
45. Ahmed, A. and Keeffe, E.B. (1999) "Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection", Am. J. Gastroenterol. 94, 249-251.
46. Tang, S.N., Ho, S.K., Moniri, K., Neng Lai, K. and Mao Chan, T. (2002) "Efficacy of famciclovir in the treatment of Lamivudine resistance related to an atypical hepatitis B virus mutant", Transplantation 15, 148-151.
47. Lau, G.K.K., He, M.L., Fong, D.Y, Bartholomeusz, A., Au, W.Y., Lie, A.K., Locarnini, S. and Liang, R. (2002) "Preemptive use of lamivuidine reduces hepatitis B exacerbation after allogeneic haematopoietic cell transplantation", Hepatology 36(3), 702-709.
48. Chan, T.M., Fang, G.X., Tang, C.S., Cheng, I.K., Lai, K.N. and Ho, S.K. (2002) "Preemptive lamuvidine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients", Hepatology 36(5), 1246-1252.
49. Leung, N. (2000) "Nucleoside analogues in the treatment of chronic hepatitis B", J. Gastroenterol. Hepatol. 15, E53-E60.
50. Hussain, M. and Lok, A.S. (1999) "Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B", J. Viral Hepat. 6, 183-194.
51. Buckwold, V.E., Xu, Z., Chen, M., Yen, T.S. and Ou, J.H. (1996) "Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication", J. Virol. 70, 5845-5851.
52. Orito, E., Mizokami, M., Sakugawa, H., et al. (2001) "A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group", Hepatology 33, 218-223.
53. Kao, J.H., Chen, P.J., Lai, M.Y and Chen, D.S. (2000) "Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B", Gastroenterology 118, 554-559.
54. Shaw, T. and Locarnini, S. (2000) "Combination chemotherapy for hepatitis B virus: the final solution?", Hepatology 32, 430-432.
55. Marcellin, P. (2002) "Advances in therapy for chronic hepatitis B", Semin. Liver. Dis. 22(Suppl. 1), 33-36.
56. Liaw, Y.F. (2002) "Therapy of chronic hepatitis B: current challenges and opportunities", J. Viral Hepat. 9(6), 393-399.
57. Delaney, IV, W.E., Edwards, R., Colledge, D., Shaw, T., Furman, P., Painter, G. and Locarnini, S. (2002) "Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro", Antimicrob. Agents Chemother. 46(9), 3057-3060.